Corporate Services for Your Business in Singapore
WhatsApp
WeChat⌄
Apex Gateway WeChat QR code

Scan to contact us on WeChat

Mobile: +65 8585 9090Email: [email protected]
Taxes · PDF

Biomedical Research and Manufacturing: GST Guide

The tenth edition separates clinical research import relief, contract-manufacturing concessions and the tax treatment of research funding.

Source checked · 11 October 2026 · Document date: 30 Jan 2026

Use the correct relief route

Specified medicines, therapeutic products and Class 2 cell, tissue or gene therapy products and placebos may receive Customs import relief for regulated trials, re-export or compliant destruction. The materials must meet the restrictions on legal trading and private consumption. Qualifying active-pharmaceutical-ingredient contract manufacturers can apply for ACMT; benefits are conditional and do not extend automatically to local clients or ordinary GST-registered overseas clients.

Analyse grants and research services

An unconditional grant without a direct return benefit is generally outside GST. IP ownership, rights to use results or income-sharing can instead create consideration for a supply. Distinguish grant-monitoring reports from benefits actually consumed by the funder. Overseas R&D zero-rating requires the contractual recipient, direct beneficiary and connection-to-local-goods or land tests; overseas payment alone is insufficient. Retain grant agreements, service flows and import records before determining output tax and eligible input recovery.

Official source

A concise, independent Apex Gateway guide based on the official English source, not a reproduction of the complete document. Consult the original for full conditions, exceptions and subsequent updates.

Read the official PDF ↗
Contact Us